Life Sciences: Domestic | Europe

Van Bael & Bellis is a prominent domestic life sciences practice advising an impressive roster of international biotechnology and pharmaceutical companies on interactions with the Belgian regulator and Belgian interpretation of EU legislation. It assists clients with a range of regulatory work relating to clinical trials, product distribution and market entry for new products. The law firm further represents clients in contentious matters before the Belgian courts relating to reimbursement concerns and product liability. The team is also able to collaborate with the firm's competition department on issues such as information sharing between pharmaceutical companies.

HOYNG ROKH MONEGIER has an impressive practice representing innovative pharmaceutical companies in EU regulatory matters. The law firm advises clients on market authorisations, market access and product registration. It also assists clients with pricing and reimbursement mandates, as well as off-label usage. The life sciences team regularly works alongside the firm's highly regarded intellectual property practice to assist pharmaceutical companies with patent matters, including parallel import cases.

QUINZ is a prominent domestic boutique with a strong client base among international pharmaceutical companies. It acts on a broad range of Belgian regulatory matters, including consortium agreements, collaboration and licence agreements and product distribution. The law firm further assists with pricing files, market access and clinical trials.

ALTIUS acts on a broad range of regulatory matters, with a particular focus on regulations concerning plant protection and food additives, as well as medical devices and medicinal products. The law firm advises pharmaceutical and agrochemical companies on market access, clinical trials and restrictions on the export of medical equipment. It also assists with medical procurement matters. The life sciences team collaborates with the firm's market-leading intellectual property team to represent pharmaceutical companies in contentious patent proceedings.

The team at Bird & Bird is highly respected for acting for a range of clients, including biotechnology and medical device companies and market-leading pharmaceutical companies, on EU directives. It offers a full range of life sciences advice, including collaboration and technology transfer agreements, clinical trial matters and data exclusivity. Additionally, the law firm assists with complex regulatory questions and interactions with Belgian regulators. Team members also advise on marketing authorisations.

Crowell & Moring assists clients with market authorisation and product marketing matters. The law firm represents clients in cooperation agreements and licensing disputes, as well as advising on compliance with the Belgian regulatory requirements for medical devices. It works alongside the firm's highly regarded intellectual property team to represent clients from the life sciences sector in litigation relating to patent infringement.